OraSure Stock Hits New 52-Week High (OSUR)

NEW YORK ( TheStreet) -- OraSure Technologies (Nasdaq: OSUR) hit a new 52-week high Monday as it is currently trading at $11.71, above its previous 52-week high of $11.58 with 279,966 shares traded as of 2:15 p.m. ET. Average volume has been 268,700 shares over the past 30 days.

OraSure has a market cap of $516.6 million and is part of the health care sector and health services industry. Shares are up 24.6% year to date as of the close of trading on Friday.

OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States and internationally. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing.

TheStreet Ratings rates OraSure as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. You can view the full OraSure Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Stocks Under $10 Portfolio: Not Resting on Our Laurels

Stocks Under $10 Portfolio: Not Resting on Our Laurels

How to Cash in on the Fight Against the Zika Virus

How to Cash in on the Fight Against the Zika Virus

OraSure (OSUR) Stock Spikes, Upgraded at Stephens

OraSure (OSUR) Stock Spikes, Upgraded at Stephens

4 Stocks for Fighting Zika

4 Stocks for Fighting Zika

OraSure Technologies (OSUR) Stock Jumps on Zika Test Contract

OraSure Technologies (OSUR) Stock Jumps on Zika Test Contract